Related Experiment Videos
Phosphodiesterase 7A-deficient mice have functional T cells
Guchen Yang1, Kim W McIntyre, Robert M Townsend
1Immunology and Inflammation Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA. guchen.yang@bms.com
Journal of Immunology (Baltimore, Md. : 1950)
|December 10, 2003
Summary
Phosphodiesterase 7A (PDE7A) is not essential for T cell activation. Targeted gene disruption in PDE7A knockout mice revealed normal T cell proliferation and cytokine production, with an unexpected increase in antibody response.
Area of Science:
- Immunology
- Molecular Biology
- Enzymology
Background:
- Phosphodiesterases (PDEs) regulate cyclic nucleotide signaling, impacting leukocyte functions.
- PDE7A has been implicated in T lymphocyte activation, with inhibition suppressing proliferation and IL-2 production.
- This led to the hypothesis that PDE7 inhibitors could treat T cell-mediated autoimmune diseases.
Purpose of the Study:
- To investigate the role of PDE7A in T cell activation using targeted gene disruption.
- To determine if PDE7A is essential for T lymphocyte proliferation and cytokine production.
- To assess the impact of PDE7A deficiency on adaptive immune responses.
Main Methods:
- Generation and analysis of PDE7A knockout mice (PDE7A(-/-)).
- Assessment of T cell proliferation and Th1/Th2 cytokine production upon CD3/CD28 costimulation.
- Evaluation of antibody (Ab) response to a T cell-dependent antigen (keyhole limpet hemocyanin).
Main Results:
- PDE7A knockout mice exhibited normal T cell proliferation and Th1/Th2 cytokine production.
- No deficiencies in T cell activation were observed in the absence of PDE7A.
- Surprisingly, PDE7A(-/-) mice showed a significantly elevated antibody response to keyhole limpet hemocyanin.
Conclusions:
- PDE7A is not essential for T cell activation, challenging previous assumptions.
- Targeting PDE7A may not be a viable strategy for treating T cell-mediated autoimmune diseases.
- PDE7A may play a regulatory role in antibody production rather than T cell activation.